The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Overexpression of p16INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri
Open accessAbstract
Cytological screening for cervical cancer or its precursors using Papanicolaou's smear test (Pap test) has been highly efficient to reduce the morbidity and mortality of cervical cancer. However, evaluation of the Pap test relies on subjective diagnostic parameters and is affected by a high rate of false-positive and false-negative results. More objective diagnostic parameters to identify truly dysplastic or neoplastic cells in cervical smears as well as in cervical biopsy samples would therefore avoid insecurity for many patients and the high screening costs associated with repeated testing. Cervical dysplasia is induced by persistent infections through high-risk types of human papillomaviruses (HPVs). Outgrowth of dysplastic lesions is triggered by increasing expression of two viral oncogenes, E6 and E7, which both interact with various cell cycle-regulating proteins. Among these is the retinoblastoma gene product pRB, which is inactivated by E7. pRB inhibits transcription of the cyclin-dependent kinase inhibitor gene p16(INK4a). Increasing expression of the viral oncogenes in dysplastic cervical cells might thus be reflected by increased expression of p16(INK4a). In line with this hypothesis, we observed marked overexpression of p16(INK4a) in all cervical intraepithelial neoplasm (CIN) I lesions (n = 47) except those associated with low-risk HPV types (n = 7), all CIN II lesions (n = 32), all CIN III lesions (n = 60) and 58 of 60 invasive cervical cancers. In contrast, no detectable expression of p16(INK4a) was observed in normal cervical epithelium (n = 42), inflammatory lesions (n = 48) and low-grade cervical lesions (CIN I) associated with low-risk HPV types (n = 7). Dysplastic cells could also be identified in cervical smears using a specific p16(INK4a) monoclonal antibody. These data demonstrate that p16(INK4a) is a specific biomarker to identify dysplastic cervical epithelia in sections of cervical biopsy samples or cervical smears.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Erlich, H. A., & Arnheim, N. (1985) · Science · doi:10.1126/science.2999980 · Cited by 8,956
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,054
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742
Estimates of the worldwide incidence of eighteen major cancers in 1985
Parkin, D. M., Pisani, P., & Ferlay, J. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540413 · Cited by 1,638
E2F: a Link Between the Rb Tumor Suppressor Protein and Viral Oncoproteins
Nevins, J. R. (1992) · Science · doi:10.1126/science.1411535 · Cited by 1,506
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
Hausen, H. Z. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.690 · Cited by 1,298
de Roda Husman, A.-M., Walboomers, J. M. M., van den Brule, A. J. C., Meijer, C. J. L. M., & Snijders, P. J. F. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-4-1057 · Cited by 1,283
Schiffman, M. H., Bauer, H. M., Hoover, R. N., Glass, A. G., Cadell, D. M., Rush, B. B., Scott, D. R., Sherman, M. E., Kurman, R. J., Wacholder, S., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.12.958 · Cited by 1,210
Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., & Kern, S. E. (1994) · Nature Genetics · doi:10.1038/ng0994-27 · Cited by 1,136
Germline p16 mutations in familial melanoma
Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S., Sheahan, M. D., Clark, W. H., Tucker, M. A., & Dracopoli, N. C. (1994) · Nature Genetics · doi:10.1038/ng0994-15 · Cited by 977
Münger, K., Werness, B. A., Dyson, N., Phelps, W. C., Harlow, E., & Howley, P. M. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08594.x · Cited by 964
Belinsky, S. A., Nikula, K. J., Palmisano, W. A., Michels, R., Saccomanno, G., Gabrielson, E., Baylin, S. B., & Herman, J. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11891 · Cited by 956
A New Procedure for Staining Vaginal Smears
Papanicolaou, G. N. (1942) · Science · doi:10.1126/science.95.2469.438 · Cited by 676
Lăără, E., Day, N., & Hakama, M. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92695-x · Cited by 657
Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
Cairns, P., Polascik, T. J., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-210 · Cited by 627
Chellappan, S., Kraus, V. B., Kroger, B., Munger, K., Howley, P. M., Phelps, W. C., & Nevins, J. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4549 · Cited by 614
Sano, T., Oyama, T., Kashiwabara, K., Fukuda, T., & Nakajima, T. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65689-1 · Cited by 579
Jacobs, M. V., Snijders, P. J., van den Brule, A. J., Helmerhorst, T. J., Meijer, C. J., & Walboomers, J. M. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.3.791-795.1997 · Cited by 568
Interim Guidelines for Management of Abnormal Cervical Cytology
Kurman, R. J. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510470070037 · Cited by 530
Rb function in cell-cycle regulation and apoptosis
Harbour, J. W., & Dean, D. C. (2000) · Nature Cell Biology · doi:10.1038/35008695 · Cited by 509
Cancer in the European community and its member states
Møller Jensen, O., Estève, J., Møller, H., & Renard, H. (1990) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(90)90278-2 · Cited by 455
(ALTS) Group, T. A. S. C. O. U. S. /.-G. S. I. L. T. S. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.5.397 · Cited by 438
PHAGOCYTOSIS IN CHRONIC GRANULOMATOUS DISEASE
De Gast, G. C., Ydema, W., Wiersma, M., & Dankert, J. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92245-x · Cited by 361
Li, Y., Nichols, M. A., Shay, J. W., & Xiong, Y. (1994) · PubMed · Cited by 359
Khleif, S. N., DeGregori, J., Yee, C. L., Otterson, G. A., Kaye, F. J., Nevins, J. R., & Howley, P. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4350 · Cited by 358
Mori, T., Miura, K., Aoki, T., Nishihira, T., Mori, S., & Nakamura, Y. (1994) · PubMed · Cited by 333
Nuovo, G. J., Plaia, T. W., Belinsky, S. A., Baylin, S. B., & Herman, J. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12754 · Cited by 314
Papillomaviruses in Human Cancers
Zur Hausen, H. (1999) · Proceedings of the Association of American Physicians · doi:10.1046/j.1525-1381.1999.99723.x · Cited by 310
Improved cervical smear assessment using antibodies against proteins that regulate DNA replication
Williams, G. H., Romanowski, P., Morris, L., Madine, M., Mills, A. D., Stoeber, K., Marr, J., Laskey, R. A., & Coleman, N. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14932 · Cited by 310
The National Co-ordinating Network for Cervical Screening Working Group, Sasieni, P., Cuzick, J., & Lynch-Farmery, E. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.196 · Cited by 292
International trends in incidence of cervical cancer: II. Squamous-cell carcinoma
Vizcaino, A. P., Moreno, V., Bosch, F. X., Mu�oz, N., Barros-Dios, X. M., Borras, J., & Parkin, D. M. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000501)86:3<429::aid-ijc20>3.0.co;2-d · Cited by 285
Doeberitz, M. V. K., Oltersdorf, T., Schwarz, E., & Gissmann, L. (1988) · PubMed · Cited by 283
Papillomaviruses in Human Cancers
Hausen, H. Z. (2003) · Infectious Causes of Cancer · doi:10.1385/1-59259-024-1:245 · Cited by 238
Organisation and results of the cervical cytology screening programme in British Columbia, 1955-85
Anderson, G. H., Boyes, D. A., Benedet, J. L., Le Riche, J. C., Matisic, J. P., Suen, K. C., Worth, A. J., Millner, A., & Bennett, O. M. (1988) · BMJ · doi:10.1136/bmj.296.6627.975 · Cited by 229
Dürst, M., Glitz, D., Schneider, A., & zur Hausen, H. (1992) · Virology · doi:10.1016/0042-6822(92)90688-l · Cited by 220
Sano, T., Oyama, T., Kashiwabara, K., Fukuda, T., & Nakajima, T. (1998) · Pathology International · doi:10.1111/j.1440-1827.1998.tb03954.x · Cited by 141
Human papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
Cromme, F. V., Meijer, C. J. L. M., Snijders, P. J. F., Uyterlinde, A. M., Kenemans, P., Helmerhorst, T. J. M., Stern, P. L., van den Brule, A., & Walboomers, J. M. M. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.254 · Cited by 122
McCluggage, W. G., Walsh, M., Thornton, C. M., Hamilton, P. W., Date, A., Caughley, L., & Bharucha, H. (1998) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1998.tb10054.x · Cited by 119
Walker, D., Duan, W., Popovic, E. A., Kaye, A. H., Tomlinson, F. H., & Lavin, M. F. (1995) · PubMed · Cited by 119
Isacson, C., Kessis, T. D., Hedrick, L., & Cho, K. R. (1996) · PubMed · Cited by 100
Alteration of p16 and p15 genes in human uterine tumours
Nakashima, R., Fujita, M., Enomoto, T., Haba, T., Yoshino, K., Wada, H., Kurachi, H., Sasaki, M., Wakasa, K., Inoue, M., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690379 · Cited by 95
Monoclonal antibodies Ki‐S3 and Ki‐S5 yield new data on the ‘Ki‐67’proteins
Heidebrecht, H. J., Buck, F., Haas, K., Wacker, H. H., & Parwaresch, R. M. (1996) · Cell Proliferation · doi:10.1111/j.1365-2184.1996.tb00984.x · Cited by 92
Al‐Saleh, W., Delvenne, P., Greimers, R., Fridman, V., Doyen, J., & Boniver, J. (1995) · American Journal of Clinical Pathology · doi:10.1093/ajcp/104.2.154 · Cited by 84
Epidemiology of cervical cancer.
Herrero, R. (1996) · PubMed · Cited by 72
Cervical screening adjuncts: Recent advances
Spitzer, M. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70393-x · Cited by 61
Cost-Effectiveness of Rescreening Conventionally Prepared Cervical Smears by PAPNET Testing
Schechter, C. B. (1996) · Acta Cytologica · doi:10.1159/000334021 · Cited by 42
p16andp15Alterations in Primary Gynecologic Malignancy
Wong, Y. F., Chung, T. K. H., Cheung, T. H., Nobori, T., Yim, S. F., Lai, K. W. H., Yu, A. L.-T., Diccianni, M. B., Li, T. Z., & Chang, A. M. Z. (1997) · Gynecologic Oncology · doi:10.1006/gyno.1997.4669 · Cited by 42
Underexpression of Cyclin-Dependent Kinase (CDK) Inhibitors in Cervical Carcinoma
Kim, Y. T., Cho, N. H., Park, S. W., & Kim, J. W. (1998) · Gynecologic Oncology · doi:10.1006/gyno.1998.5134 · Cited by 42
Bias versus causality: Interpreting recent evidence of oral contraceptive studies
Spitzer, W. O. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1053/ob.1998.v179.a93059 · Cited by 40
Kim, J. W., Namkoong, S. E., Ryu, S. W., Kim, H. S., Shin, J. W., Lee, J. M., Kim, D. H., & Kim, I. K. (1998) · Gynecologic Oncology · doi:10.1006/gyno.1998.5041 · Cited by 36
CDKN2 in HPV‐positive and HPV‐negative cervical‐carcinoma cell lines
Kelley, M. J., Otterson, G. A., Kaye, F. J., Popescu, N. C., Johnson, B. E., & DiPaolo, J. A. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630214 · Cited by 36
Hirama, T., Cw, M., Wilczynski, S. P., & Hp, K. (1996) · PubMed · Cited by 34
Alterations of the p16INK4A gene in human ovarian cancers
Kanuma, T., Nishida, J., Gima, T., Barrett, J. C., & Wake, N. (1997) · Molecular Carcinogenesis · Cited by 19
Hakama, M. (1996) · Cancer treatment and research · doi:10.1007/978-1-4613-1265-9_4 · Cited by 10
Cited by
Papillomaviruses and cancer: from basic studies to clinical application
zur Hausen, H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc798 · Cited by 4,024
Darragh, T. M., Colgan, T. J., Cox, J. T., Heller, D. S., Henry, M. R., Luff, R. D., McCalmont, T., Nayar, R., Palefsky, J. M., Stoler, M. H., et al. (2012) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.lgt200570 · Cited by 1,007
Darragh, T. M., Colgan, T. J., Thomas Cox, J., Heller, D. S., Henry, M. R., Luff, R. D., McCalmont, T., Nayar, R., Palefsky, J. M., Stoler, M. H., et al. (2013) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31826916c7 · Cited by 571
Gillison, M. L. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.09.011 · Cited by 549
Darragh, T. M., Colgan, T. J., Cox, J. T., Heller, D. S., Henry, M. R., Luff, R. D., McCalmont, T., Nayar, R., Palefsky, J. M., Stoler, M. H., et al. (2012) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e31825c31dd · Cited by 494
Metadata
- Authors
- Klaes, R., Friedrich, T., Spitkovsky, D., Ridder, R., Rudy, W., Petry, U., Dallenbach-Hellweg, G., Schmidt, D., & von Knebel Doeberitz, M.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2001
- Volume
- 92
- Issue
- 2
- Pages
- 276-284
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1998218812
- Cited by
- 1,035
- References
- 58
- FWCI
- 31.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.